8RNE
HLA-E*01:03 in complex with SARS-CoV-2 Nsp13 peptide, VMPLSAPTL
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | MAX IV BEAMLINE BioMAX |
Synchrotron site | MAX IV |
Beamline | BioMAX |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2023-06-09 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.97625 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 120.493, 67.597, 152.228 |
Unit cell angles | 90.00, 92.78, 90.00 |
Refinement procedure
Resolution | 46.110 - 1.710 |
Rwork | 0.204 |
R-free | 0.24330 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.006 |
RMSD bond angle | 1.469 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.110 | 1.740 |
High resolution limit [Å] | 1.710 | 1.710 |
Rmerge | 0.070 | 1.252 |
Rmeas | 0.083 | |
Rpim | 0.044 | 0.774 |
Number of reflections | 132063 | 6521 |
<I/σ(I)> | 11.7 | 1.4 |
Completeness [%] | 99.9 | 100 |
Redundancy | 2 | |
CC(1/2) | 0.999 | 0.628 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293.15 | 0.15 M potassium bromide, 20% w/v of PEG 2000 MME |